Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -20.00p -5.06% 375.00p 370.00p 380.00p 395.00p 375.00p 395.00p 127,821 14:27:48
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 67.2 13.9 14.2 26.4 251.70

Eco Animal Health Share Discussion Threads

Showing 601 to 624 of 1025 messages
Chat Pages: Latest  29  28  27  26  25  24  23  22  21  20  19  18  Older
DateSubjectAuthorDiscuss
28/4/2016
10:10
Well, just maybe. But these shares are tightly held and it doesn't take much buying to push the price up. On the other hand somebody acquired 250,000 recently without moving the price. How did they do that?
aimingupward2
27/4/2016
15:44
I think that any acquirer will be starting to make noises to be ahead of the pack! They will defo want aivlosin and be able to take out the central costs as well as having its own distribution. But agree something is likely to be up, just like the share price
smelleroo
27/4/2016
15:10
I'm beginning to wonder if they are in discussions about selling the company as the share price just keeps heading north. Either that or someone is in the know about revenues markedly exceeding expectations. The mysterious peel hunt note may enlighten us. Whatever the driver, long may it continue!
audigger
27/4/2016
09:09
Any buying back by the company would be announced to the market the day after. I am still trying to find the notes from peel hunt on Eco as they are v keen! Cannot find anything on the Internet
smelleroo
27/4/2016
08:25
It may, of course be institutional buying, but I had wondered whether the company might buy some more of it's own shares. Very few have been bought since authorisation to do was put in place.
aimingupward2
27/4/2016
08:12
Well spotted, I hadn't picked up on that news. Another tick up to start the day. The article confirms that they have a zero day withholding period in the USA but I still haven't been able to confirm whether or not this is now the case in the EU. Will do some digging!
audigger
27/4/2016
07:47
Pharmgate Animal Health launches Aivlosin 17% Tylvalosin Apr 26, 2016 Ileitis can have a serious impact on swine producers’ profitability. Ileitis, particularly the chronic form, remains widespread on many swine operations, resulting in poor feed conversion and weight gains. Clinical signs may be subtle or absent; diagnosis by serology or polymerase chain reaction will confirm the presence of the disease. Veterinarians and producers can improve production performance through pig flow management and targeted treatment to reduce this form of the disease, a costly threat. Aivlosin 17% Tylvalosin Type A Medicated Article from Pharmgate Animal Health administered as a sole ration in the feed is effective in reducing clinical signs, mortality, intestinal lesions and performance suppression associated with porcine proliferative enteritis associated with Lawsonia intracellularis infection in swine where the disease has become endemic in groups of pigs in a house or on a farm Under the prescription of a veterinarian, Aivlosin 17% is administered at a level of 38.6 grams per ton in complete finished feed for 14 consecutive days to provide 2.125 milligrams tylvalosin per kilogram body weight daily, offering both a low therapeutic dose rate and short medication duration. No withdrawal period is required, a great benefit when breakdowns occur in late finishers. Furthermore, the clinical efficacy, low therapeutic dose rate, and brief treatment duration are all in accordance with best practices for contemporary commercial swine units and judicious antibiotic use Dan Rosener, technical services director for Pharmgate Animal Health, North America, summarizes it all: “Where Aivlosin Water Soluble Granules has met with widespread acclaim from veterinarians and producers in North America for its fast speed of action in the face of an outbreak, the launch of Aivlosin 17% now allows veterinarians greater flexibility when dealing with the control of subclinical, chronic cases of ileitis. Field efficacy and improved clinical results have been demonstrated since the launch two years ago in Canada. With global concerns about the use of antibiotics, this new medication option, with its low medication dose rate, short treatment time and zero-day withdrawal period fulfills the requirements for the judicious use of antimicrobials in modern pig production.”
smelleroo
26/4/2016
17:05
Have been for a while now ! Peel hunt are very keen on this and I can understand why
smelleroo
26/4/2016
15:04
Some reasonable volume today. Institutions adding?
audigger
25/4/2016
13:55
Breakout continues....
audigger
22/4/2016
10:45
It was 2 days for meat of offal. This may have changed but I haven't been able to find confirmation of this
audigger
22/4/2016
09:44
I've not double checked, Au, but I thought they had got a zero day withholding period for pigs.
aimingupward2
22/4/2016
09:28
When it comes to approval of new uses in the EU, nothing is inevitable. It takes a lot of effort in terms of data generation and discussions with regulators, often over a number of years, to secure such approvals. It's good that they have secured a zero day withholding period. I don't think they have this yet for other uses in the E U such as pigs, however they will almost certainly be working on it.
audigger
22/4/2016
09:15
This morning's rns is really encouraging further confirmation of EAH's potential. I just wonder, though, how the ambition to make the company a major force in the international market for veterinary products squares with what has tended to be the view that it will be bought out. They're not necessarily alternatives, of course, but the more emphasis is given to the former, the more delayed would be the latter. Either way, it's a comfortingly reliable investment to hold on to. I would add if any weakness occurs over the summer.
aimingupward2
22/4/2016
08:44
surely the wider used aivlosin is becoming, makes things inevitable here........in my opinion anyway
smelleroo
22/4/2016
07:18
Eggcellent news (sorry!). As I posted on March 31st use in egg laying hens was a rather big gap in the EAH offer so this is a really significant step forward. I don't know the numbers but there must be potential to sell significant volumes of product at a decent margin in to this market segment. All bodes well for further step changes in the bottom line
audigger
22/4/2016
07:10
good news continues to go the right way
smelleroo
19/4/2016
09:12
Would be nice to get a trading above expectations RNS! I wonder if they make think about moving away from AIM and listing on the main index? Involves lots of admin costs I know but would certainly increase visibility. Final results in July will be the next expected milestone and hopefully they will be hugely impressive helped further by the relatively weak pound. I wonder where they got to with exploring the anti-viral potential of Aivlosin.....I think they had some research ongoing at Cambridge Uni but this seems to have never come to fruition.
audigger
18/4/2016
19:54
I spoke to my broker who has seen the note. He was saying that there was seem decent emphasis in the note about the attractiveness to a third party primarily in relation to aivlosin. They seem very upbeat about trading too! I haven't seen but broker was saying peel hunt seem pretty upbeat about eco
smelleroo
14/4/2016
19:24
Anyone else heard that the broker wrote a note on Eco suggesting could be attractive to an acquirer?
smelleroo
07/4/2016
15:47
nice to see some volume today
smelleroo
01/4/2016
21:17
I have held a position for over a decade! Have waited a long time for PL to build this company. To give him credit, he has done that! This is v good medicine which will attract buyers as barriers to entry are so big. No one is going to go through what Eco has done when they can just buy Eco. Worth pointing out the PL isn't getting any younger but there are big synergies here for a trade buyer. I am upbeat for next set of results as I would expect good overseas business growth in China and us as well benefits of strong dollar. Peel hunt, the brokers, have this as one of their sticks for 2016. Good call so far! Will it see out the remainder of 2016, that has to be a question on many people's minds
smelleroo
01/4/2016
20:21
I've definitely not re-branded! My impression with this company is that if they were sold to a global company margins would be much higher and central costs virtually disappear. Think this does genuinely have the possibility of doubling or tripling from here - the business could be worth a lot more in the right hands. Of course, the sales momentum needs to be maintained. Bought mine at 93p so definitely doing very well. Shame I didn't buy more than I did back in 2008!
topvest
01/4/2016
16:45
Too many times I've seen a paper profit evaporate in to a paper loss.....I thinkin Soros said his greatest regret was closing winning positions too soon. He did ok though! I'm going to hold these until interims....when I expect only good news as the bottom line continues to grow with the US business starting to fully kick in. Wish I'd sold my RBS shares at 400.....
audigger
Chat Pages: Latest  29  28  27  26  25  24  23  22  21  20  19  18  Older
Your Recent History
LSE
EAH
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190521 01:00:48